Insulet Corporation to Present at the 30th Annual J.P. Morgan Healthcare Conference
(firmenpresse) - BEDFORD, MA -- (Marketwire) -- 01/04/12 -- Insulet Corporation (NASDAQ: PODD), the leader in technology with its OmniPod® Insulin Management System, today announced the Company will participate in the 30th Annual J.P. Morgan Healthcare Conference at the Westin St. Francis Hotel in San Francisco. Management is scheduled to present an overview of the Company on Tuesday, January 10, 2012 at 2:00 p.m. PT (5:00 p.m. ET).
During the presentation, material information concerning the Company, its operations, strategies and prospects may be discussed. To listen to audio webcasts of the presentations during the event, please visit: . A replay of each webcast will be available for 10 days after the initial presentation.
Insulet Corporation is an innovative medical device company dedicated to making the lives of people with diabetes easier. Through its OmniPod Insulin Management System, Insulet seeks to expand the use of among people with insulin-dependent diabetes. The OmniPod is a revolutionary and easy-to-use tubeless insulin pump that features just two parts and fully-automated cannula insertion. Founded in 2000, Insulet Corporation is based in Bedford, Mass. For more information, please visit: .
Stephanie Marks for Insulet Corporation
212-843-0211
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 04.01.2012 - 21:15 Uhr
Sprache: Deutsch
News-ID 101189
Anzahl Zeichen: 0
contact information:
Town:
BEDFORD, MA
Kategorie:
Healthcare
Diese Pressemitteilung wurde bisher 215 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Insulet Corporation to Present at the 30th Annual J.P. Morgan Healthcare Conference"
steht unter der journalistisch-redaktionellen Verantwortung von
Insulet Corporation (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
